Children's National Hospital
Locations
Transplant Summary
Overview
Our FACT-accredited program was established in 1988 and has been an NMDP transplant center since September 1992. We have performed over 657 allogeneic and 717 autologous pediatric transplants. The current focus of our program is on alternative donor transplants (haploidentical, cord blood, bone marrow and PBSC) and the evaluation of non-myeloablative approaches for the treatment of non-malignant pediatric diseases. Additionally, we focus heavily on the use of cellular therapy for the treatment of malignancies and viral infections. We are a CAR-T site for leukemia patients and are one of the largest programs in the country for pediatric sickle cell transplants. We provide extracorporeal photopheresis for patients. This center is part of the Children's Oncology Group (COG), the PTCTC (Pediatric Transplantation and Cellular Therapy Consortium), and the BMT CTN (Clinical Trials Network).This center has been performing allogeneic transplants since 1988 and has been an NMDP transplant center since September 1992.
Attending physicians
Adult - Catherine Bollard, Elizabeth Hicks, David Jacobsohn, Mamatha Mandava, Evelio Perez, Anant Vatsayan
Pediatric - Catherine Bollard, Elizabeth Hicks, David Jacobsohn, Mamatha Mandava, Evelio Perez, Anant VatsayanTransplants performed
Marrow/PBSC, single cord, and double cordCord blood transplants
Pediatric onlyOther programs and services
Our center has multiple licensed social workers and clinical nurse coordinators. They perform significant teaching pre-transplant to ensure families understand the process and know the Team. They assist with discharge planning and issues as they arise during the admission and clinic visits. We have a dedicated psychologist that works with the clinicians and the patients. We offer multi-disciplinary care to our patients, and involve music therapy, therapeutic art services, family support services, and on-site school assistance. Patients and families can access the beautiful and therapeutic healing garden. Patients are managed in the dedicated inpatient BMT unit (11 HEPA-filtered, positive pressure suites and the dedicated outpatient BMT clinic (5 rooms). Parents can spend the night and visit with their children. After discharge families are able to stay at the Ronald McDonald House where there are 4 private apartments within the house for BMT families that offer a living area, bedroom, kitchen and full sized refrigerator and microwave. Grocery delivery services are available. The Ronald McDonald House is located a short drive from the hospital in the Brookland area of DC and offers off street parking.Patient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 95 patients.The actual 1-year survival of these patients is 94.5%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 84.9% and 95.9%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.
The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.
Total pediatric transplants
144
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow45PBSC36Cord blood3Total84Unrelated donorMarrow12PBSC2Cord blood4Total18Total allogeneicMarrow57PBSC38Cord blood7Total102AutologousMarrowBoth marrow & PBSC 42PBSC—Cord blood—Total42Total combinedMarrowBoth marrow & PBSC 137PBSC—Cord blood7Total144All Diseases
Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)
0-18 19-44 45-64 65+ Total Related 0-187919-44545-64065+0Total84Unrelated 0-181619-44245-64065+0Total18Autologous 0-184219-44045-64065+0Total42Total 0-1813719-44745-64065+0Total144Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants can be found:
- U.S. Transplant Data by Center (Opens in a new tab) report at blood cell.transplant.hrsa.gov
- List of diseases
Transplant center resources
Transplant center coordinatorSamrawit BerhanePhone: (202) 476-5456If you have questions about costs and financial services at this center, please call the transplant center’s direct phone number.NMDP patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
- Inside the United States: 1 (888) 999-6743
- Outside the United States: 1 (763) 406-3410. (Long distance or international charges may apply.)
Email: patientinfo@nmdp.org
More resources
- Choosing a transplant center
- Preparing for transplant
- Learn about transplant outcomes and treatment decisions (Opens in a new tab)
- Support and resources (including non-English materials)
- U.S. Transplant Data by Center (Opens in a new tab) at blood cell.transplant.hrsa.gov
Bone Marrow Transplant Long term Follow up Program
111 Michigan Ave Washington, DC 20010 Phone:202-476-6024 Physician Referrals:202-476-4267 For more information about this program: https://www.childrensnational.org/get-care/departments/blood-and-marrow-transplantation-long-term-follow-up-program (Opens in a new tab)Overview
At Children's National Health System, we are committed to enhancing your child's quality of life after he or she has had a blood and marrow transplant (BMT). We've designed the BMT Long-Term Follow-up Program to provide ongoing support to allogeneic transplant patients whether their treatment was for cancer, sickle cell disease or a non-cancerous immunodeficiency. One year after your child's BMT, he or she will be seen in our program and will continue with annual checkups as frequently as needed. Visits include a comprehensive review of your child's overall health, designed to check the status of the disease for which he or she received the transplant. Additionally, we will evaluate the function of the new immune system and recommend different methods of preventing infections as appropriate. Our expert physicians and nurses will also monitor for any complications related to the transplantation, working together to manage both short and long-term side effects. Early intervention by our highly-trained team can result in fewer complications.
Staff
Program Director:Blachy J. Davila Saldana, MDProgram Coordinator:Elizabeth Stepanek, RNMedical Specialties in Program
Cardiology, dermatology, endocrinology, gynecology, neurology, Physical Medicine & Rehabilitation, psychiatry/psychology, pulmonology.Medical Services Offered
Chronic GVHD management, fertility counseling, reproductive health, Re-Vaccination Counseling, social services.Telemedicine services are available.Patient Eligibility
Children- Allogeneic transplant recipients
- 1 year after transplant.
- Patients who were transplanted as a child at this center with no upper age limit
- Does accept patients who were transplanted at another hospital
- Will admit pediatric patients who transferred into the program
- Will accept adult patients who were transplanted as a child at another center up to age 30